Jennifer Prescher

Prescher was an undergraduate in chemistry at the University of Wisconsin–La Crosse. She moved to California as a doctoral researcher, and was appointed to the University of California, Berkeley as a Howard Hughes Medical Institute predoctoral fellow, where she worked with Carolyn Bertozzi on glycosylation.[1] She developed a strategy to visualize the glycosylation process, which allowed for the design and development of novel diagnostics. The strategy relied upon the use of bioorthogonal chemistries. Specifically, she showed that it was possible to incorporate metabolic precursor sugars with specific chemical functionalities into target glycans. For example, biologically inert azides can be incorporated into glycans and chemically modified with exogenously delivered probes.[1]

In 2008, she joined Stanford University as a Susan Komen postdoctoral fellow. Prescher joined the University of California, Irvine in 2010, and was made a full professor in 2018. Her early work looked to design imaging techniques to better understand cell movements and metastatic disease.[4] She worked on bioluminescent tools; tools which luminesce when they come into close proximity to cancer cells.[4][5][6] She called the technique a biological flashlight, or phasor.[7]

• 2014 Kavli Fellow[8]
• 2014 National Science Foundation CAREER Award[4]
• 2015 Sloan Research Fellowship[9]
• 2015 Novartis early career award in organic chemistry[10]
• 2016 Thieme Medical Publishers chemistry journal award[11]
• 2016 American Chemical Society Women in Chemistry Rising Star[12]
• 2016 University of California, Irvine distinguished assistant professor award for research[13]
• 2018 Scialog Fellow[14]
• 2021 Paul Allen Distinguished Investigator[15][7]
• 2023 American Chemical Society Arthur C. Cope Scholar Award[16]

• A Comparative Study of Bioorthogonal Reactions with Azides[17]
• A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems[18]
• Chemistry in living systems[19]